They tell you to pick a day and stick with it, which is correct
Dejgaard TF, Frandsen CS, Hansen TS et al (2016) Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial
How do I know if I qualify for the GLP 1 program Wisconsin offering Wegovy or Zepbound
Stacking the two can amplify blood sugar lowering more than expected
Despite these side effects, the overall incidence of adverse events leading to discontinuation of treatment was relatively low
These include: Nausea (most common, particularly at higher doses) Vomiting Diarrhoea Constipation Decreased appetite Gastrointestinal events were generally mild to moderate in severity and tended to resolve as participants adapted to each dose level